newsfilter
← Latest News
GlobeNewswire·

Trillium Therapeutics Receives Notices of Allowance From U.S. Patent and Trademark Office

Allowance received for the use of SIRPaFc to treat both hematologic and solid tumors (method of use patent)Allowance received for the TTI-622 composition of matter patent CAMBRIDGE, Mass., Oct. 05,...